Yield10 Bioscience, a US agricultural bioscience company, has recently obtained an exclusive technology license from Rothamsted Research, a UK-based agricultural research institute, to create omega-3 products from camelina. This collaboration began in late 2020, with Yield10 supporting Rothamsted’s Flagship Program to develop omega-3 oils in camelina.
Rothamsted Research, located in Harpenden, is a renowned non-profit research center specializing in agricultural science. Their team, led by science director Prof Johnathan Napier, has successfully produced DHA and EPA oils in camelina seed over the past decade. Yield10, headquartered in Woburn and with a subsidiary in Canada, focuses on developing crop systems and utilizing its Trait Factory and Fast Field Testing system to improve seed traits for various industries.
Yield10 plans to use genetically engineered camelina to produce commercial omega-3 oil and meal products for various markets, including aquafeed, pet food, and nutritional supplements. By leveraging Rothamsted’s technology, Yield10 aims to create omega-3 producing camelina varieties. The company’s president and CEO, Oliver Peoples, stated that by 2024, they anticipate scaling up production and obtaining regulatory approvals for commercial launch.
In addition to enhancing camelina varieties as a platform crop for producing and commercializing nutritional oils, proteins
Russia's central bank chief, Elvira Nabiullina, announced on Thursday that inflation in the country was…
Saudi Arabian Netflix producer Abdulaziz Almuzaini has been sentenced to 13 years in prison and…
Hungarian Prime Minister Viktor Orban will travel to Moscow tomorrow to meet with Russian President…
A healthy diet can greatly improve sleep quality and reduce the risk of chronic diseases.…
The South African police have confirmed to ESPN that the body of former Olympian and…
The Cowboys quarterback Dak Prescott’s health has been a major concern for fans this offseason,…